Guidance
Evidence-based recommendations on biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer. This involves pushing the rectum slightly away from the prostate by inserting a balloon or injecting a gel (spacer) between them.
Is this guidance up to date?
Next review: 2026
Guidance development process
How we develop NICE interventional procedures guidance
Coding and clinical classification codes for this guidance.
This guidance replaces NICE interventional procedures guidance on biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer (IPG590).